6AT5
Crystal structure of HLA-B*07:02 in complex with an NY-ESO-1 peptide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX1 |
Synchrotron site | Australian Synchrotron |
Beamline | MX1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-01-01 |
Detector | ADSC QUANTUM 210 |
Wavelength(s) | 0.9537 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 50.194, 82.066, 112.047 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 28.146 - 1.500 |
R-factor | 0.2116 |
Rwork | 0.211 |
R-free | 0.23000 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.005 |
RMSD bond angle | 0.952 |
Data reduction software | XDS |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX (1.9_1692) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.270 | 1.580 |
High resolution limit [Å] | 1.500 | 1.500 |
Rmerge | 0.121 | 0.564 |
Rpim | 0.051 | 0.224 |
Number of reflections | 74669 | 10830 |
<I/σ(I)> | 8.5 | 2.9 |
Completeness [%] | 99.7 | 100 |
Redundancy | 6.9 | 7.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 277 | 0.2 M NaCl and 20 % PEG 3350 |